Long-Term Quality of Life of Vestibular Schwannoma Patients: A Longitudinal Analysis.
long-term
quality of life
radiotherapy
surgery
vestibular schwannoma
Journal
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
ISSN: 1097-6817
Titre abrégé: Otolaryngol Head Neck Surg
Pays: England
ID NLM: 8508176
Informations de publication
Date de publication:
02 2023
02 2023
Historique:
received:
21
01
2022
accepted:
03
03
2022
pubmed:
30
3
2022
medline:
9
3
2023
entrez:
29
3
2022
Statut:
ppublish
Résumé
Vestibular schwannoma management aims to maintain optimal quality of life (QoL) while preventing severe sequelae of the tumor or its treatment. This study assessed long-term QoL of patients with vestibular schwannoma in relation to treatment modality and decisional regret. A longitudinal study, in which clinical and QoL data were used that were cross-sectionally acquired in 2014 and again in 2020 from the same patient group. A tertiary expert center for vestibular schwannoma care in the Netherlands. QoL was measured by the Penn Acoustic Quality of Life (PANQOL) scale. Changes in time were assed using a linear mixed model. In addition, the Decision Regret Scale was analyzed. Of 867 patients, 536 responded (62%), with a median follow-up of 11 years. All PANQOL subdomain scores remained stable over time and did not exceed minimal clinically important difference (MCID) levels. Time since treatment did not affect QoL. Patients had comparable average QoL scores and proportions of patients with changing QoL scores (ie, exceeding the MCID) over time, irrespective of the received initial treatment. Female patients and those who required salvage therapy (either by radiotherapy or surgery) reported a lower QoL. The latter patient group reported the highest decisional regret. On average, the long-term QoL of patients with vestibular schwannoma is comparable for patients under active surveillance and those who have received active treatment, and it remains stable over time. This suggests that, on average, preservation of QoL of patients with vestibular schwannoma is feasible when adequately managed.
Identifiants
pubmed: 35349360
doi: 10.1177/01945998221088565
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
210-217Informations de copyright
© 2022 The Authors. Otolaryngology-Head and Neck Surgery published by Wiley Periodicals LLC on behalf of American Academy of Otolaryngology-Head and Neck Surgery Foundation.
Références
Carlson ML, Link MJ. Vestibular schwannomas. N Engl J Med. 2021;384(14):1335-1348.
Møller MN, Hansen S, Miyazaki H, Stangerup S, Caye-Thomasen P. Active treatment is not indicated in the majority of patients diagnosed with a vestibular schwannoma: a review on the natural history of hearing and tumor growth. Curr Otorhinolaryngol Rep. 2014;2:242-247.
Neve OM, Soulier G, Hendriksma M, et al. Patient-reported factors that influence the vestibular schwannoma treatment decision: a qualitative study. Eur Arch Otorhinolaryngol. 2021;278(9):3237-3244.
Soulier G, Van Leeuwen BM, Putter H, et al. Quality of life in 807 patients with vestibular schwannoma: comparing treatment modalities. Otolaryngol Head Neck Surg. 2017;157(1):92-98.
Carlson ML, Tveiten OV, Driscoll CL, et al. Long-term quality of life in patients with vestibular schwannoma: an international multicenter cross-sectional study comparing microsurgery, stereotactic radiosurgery, observation, and nontumor controls. J Neurosurg. 2015;122:833-842.
Carlson ML, Tombers NM, Kerezoudis P, Celda MP, Lohse CM, Link MJ. Quality of life within the first 6 months of vestibular schwannoma diagnosis with implications for patient counseling. Otol Neurotol. 2018;39(10):e1129-e1136.
Lodder WL, Van Der Laan BFAM, Lesser TH, Leong SC. The impact of acoustic neuroma on long-term quality-of-life outcomes in the United Kingdom. Eur Arch Otorhinolaryngol. 2018;275(3):709-717.
Robinett ZN, Walz PC, Miles-Markley B, Moberly AC, Welling DB. Comparison of long-term quality-of-life outcomes in vestibular schwannoma patients. Otolaryngol Head Neck Surg. 2014;150(6):1024-1032.
Carlson ML, Tveiten ØV, Driscoll CL, et al. What drives quality of life in patients with sporadic vestibular schwannoma? Laryngoscope. 2015;125(7):1697-1702.
Shaffer BT, Cohen MS, Bigelow DC, Ruckenstein MJ. Validation of a disease-specific quality-of-life instrument for acoustic neuroma. Laryngoscope. 2010;120(8):1646-1654.
van Leeuwen BM, Herruer JM, Putter H, Jansen JC, van der Mey AG, Kaptein AA. Validating the Penn Acoustic Neuroma Quality of Life Scale in a sample of Dutch patients recently diagnosed with vestibular schwannoma. Otol Neurotol. 2013;34(5):952-957.
Kristin J, Glaas MF, Schipper J, et al. Patient quality of life after vestibular schwannoma removal: possibilities and limits to measuring different domains of patients’ wellbeing. Eur Arch Otorhinolaryngol. 2019;276(9):2441-2447.
Kerezoudis P, Yost KJ, Tombers NM, Celda MP, Carlson ML, Link MJ. Defining the minimal clinically important difference for patients with vestibular schwannoma: are all quality-of-life scores significant? Neurosurgery. 2019;85(6):779-785.
Miller LE, Brant JA, Naples JG, Bigelow DC, Lee JYK, Ruckenstein MJ. Quality of life in vestibular schwannoma patients: a longitudinal study. Otol Neurotol. 2020;41(2):e256-e261.
Carlson ML, Barnes JH, Nassiri A, et al. Prospective study of disease-specific quality-of-life in sporadic vestibular schwannoma comparing observation, radiosurgery, and microsurgery. Otol Neurotol. 2021;42(2):e199-e208.
Windisch P, Tonn J-C, Fürweger C, et al. Longitudinal changes of quality of life and hearing following radiosurgery for vestibular schwannoma. Cancers (Basel). 2021;13(6):1315.
Breivik CN, Varughese JK, Wentzel-Larsen T, Vassbotn F, Lund-Johansen M. Conservative management of vestibular schwannoma-a prospective cohort study: treatment, symptoms, and quality of life. Neurosurgery. 2012;70(5):1072-1080.
Park SS, Grills IS, Bojrab D, et al. Longitudinal assessment of quality of life and audiometric test outcomes in vestibular schwannoma patients treated with gamma knife surgery. Otol Neurotol. 2011;32(4):676-679.
Brehaut JC, O'Connor AM, Wood TJ, et al. Validation of a decision regret scale. Med Decis Making. 2003;23(4):281-292.
Statistics Netherlands. Standaard onderwijsindeling 2016. Den Haag. Accessed March 8, 2021. https://www.cbs.nl/nl-nl/onze-diensten/methoden/classificaties/onderwijs-en-beroepen/standaard-onderwijsindeling--soi--/standaard-onderwijsindeling-2016
Kanzaki J, Tos M, Sanna M, Moffat DA, Monsell EM, Berliner KI. New and modified reporting systems from the consensus meeting on systems for reporting results in vestibular schwannoma. Otol Neurotol. 2003;24(4):642-649.
McGlothlin AE, Lewis RJ. Minimal clinically important difference. JAMA. 2014;312(13):1342.
Sedaghat AR. Understanding the minimal clinically important difference (MCID) of patient-reported outcome measures. Otolaryngol Head Neck Surg. 2019;161(4):551-560.
McLaughlin EJ, Bigelow DC, Lee JY, Ruckenstein MJ. Quality of life in acoustic neuroma patients. Otol Neurotol. 2015;36(4):653-656.
Reeves MJ, Bushnell CD, Howard G, et al. Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes. Lancet Neurol. 2008;7(10):915-926.
Pettersen KI, Reikvam A, Rollag A, Stavem K. Understanding sex differences in health-related quality of life following myocardial infarction. Int J Cardiol. 2008;130(3):449-456.
Cherepanov D, Palta M, Fryback DG, Robert SA. Gender differences in health-related quality-of-life are partly explained by sociodemographic and socioeconomic variation between adult men and women in the US: evidence from four US nationally representative data sets. Qual Life Res. 2010;19(8):1115-1124.
Gijsbers van Wijk CMT, Kolk AM. Sex differences in physical symptoms: the contribution of symptom perception theory. Soc Sci Med. 1997;45(2):231-246.
Carlson ML, Tveiten ØV, Lund-Johansen M, Tombers NM, Lohse CM, Link MJ. Patient motivation and long-term satisfaction with treatment choice in vestibular schwannoma. World Neurosurg. 2018;114:e1245-e1252.
Becerra Pérez MM, Menear M, Brehaut JC, Légaré F. Extent and predictors of decision regret about health care decisions. Med Decis Making. 2016;36(6):777-790.
Johnson TP. Response rates and nonresponse errors in surveys. JAMA. 2012;307(17):1805.